ADMA FY 2016 Earnings — ADMA Biologics, Inc. Revenue & Financial Results | Market Cap Arena

ADMAADMA Biologics, Inc.

$4B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M+48.5% YoY

Gross Profit

$4M40.3% margin

Operating Income

-$17M-162.6% margin

Net Income

-$20M-183.1% margin

EPS (Diluted)

$-1.61

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$24M

Total Liabilities

$28M

Stockholders' Equity

-$4M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$7M	+48.5%
Gross Profit	$4M	$3M	+50.0%
Operating Income	-$17M	-$16M	-11.7%
Net Income	-$20M	-$18M	-8.6%